Detalhe da pesquisa
1.
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
J Infect Dis
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682569
2.
Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study.
J Infect Dis
; 223(9): 1576-1581, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887990
3.
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
J Infect Dis
; 219(11): 1799-1803, 2019 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715452
4.
Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults.
J Viral Hepat
; 26(9): 1066-1075, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31087382
5.
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
J Infect Dis
; 215(11): 1711-1719, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28591778
6.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Glob Health
; 12(2): e257-e270, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245116
7.
Reply to Poddighe.
J Infect Dis
; 216(6): 783-785, 2017 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934440
8.
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vaccine
; 41(7): 1398-1407, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681529
9.
Safety and immunogenicity of a respiratory syncytial virus prefusion F protein (RSVPreF3) candidate vaccine in older Japanese adults: A phase I, randomized, observer-blind clinical trial.
Respir Investig
; 61(2): 261-269, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641341
10.
Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue.
Am J Trop Med Hyg
; 108(4): 722-726, 2023 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878213
11.
Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults.
NPJ Vaccines
; 8(1): 75, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230978
12.
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial.
Lancet Infect Dis
; 22(7): 1062-1075, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461522
13.
Long-term persistence of immune response to the AS04-adjuvanted HPV-16/18 vaccine in Chinese girls aged 9-17 years: Results from an 8-9-year follow-up phase III open-label study.
Asia Pac J Clin Oncol
; 16(6): 392-399, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780946
14.
Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.
J Natl Cancer Inst
; 112(8): 818-828, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697384
15.
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study.
EClinicalMedicine
; 23: 100353, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32639485
16.
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years.
Hum Vaccin Immunother
; 15(7-8): 1970-1979, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268383
17.
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14â¯years: Results to month 36 from a randomized trial.
Vaccine
; 36(1): 98-106, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174109
18.
Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
Hum Vaccin Immunother
; 13(5): 972-980, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28281907
19.
Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age.
Cancer Med
; 6(11): 2723-2731, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28984053
20.
The crystal structure of the pyoverdine outer membrane receptor FpvA from Pseudomonas aeruginosa at 3.6 angstroms resolution.
J Mol Biol
; 347(1): 121-34, 2005 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-15733922